BDBM602616 5-Cyano-2-[1-[2-(4,4-dimethyl-1- piperidyl)-6-methyl-4-oxo-chromen-8- yl]ethylamino]benzoic acid::US11649227, Example 6::US20230286960, Example 6
SMILES CC(Nc1ccc(cc1C(O)=O)C#N)c1cc(C)cc2c1oc(cc2=O)N1CCC(C)(C)CC1
InChI Key InChIKey=BMEZWPSUILBTPM-UHFFFAOYSA-N
Data 4 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 4 hits for monomerid = 602616
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Petra Pharma
US Patent
Petra Pharma
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant, catalytically active human full length PIK3KA Wild-type and H1047R mutant were purchased as 1:1 complex of N-terminal 6× his tagged p110...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [H1047R](Human)
Petra Pharma
US Patent
Petra Pharma
US Patent
Affinity DataIC50: 500nMAssay Description:Recombinant, catalytically active human full length PIK3KA Wild-type and H1047R mutant were purchased as 1:1 complex of N-terminal 6× his tagged p110...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Petra Pharma
US Patent
Petra Pharma
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Recombinant, catalytically active human full length PIK3KA Wild-type and H1047R mutant were purchased as 1:1 complex of N-terminal 6×his tagged p110<...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [H1047R](Human)
Petra Pharma
US Patent
Petra Pharma
US Patent
Affinity DataIC50: 500nMAssay Description:Recombinant, catalytically active human full length PIK3KA Wild-type and H1047R mutant were purchased as 1:1 complex of N-terminal 6×his tagged p110<...More data for this Ligand-Target Pair